AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,457,000 | -16.5% | 35,194 | -23.8% | 0.00% | 0.0% |
| Q4 2021 | $1,745,000 | +102.7% | 46,178 | +76.8% | 0.00% | – |
| Q3 2021 | $861,000 | -10.5% | 26,118 | +83.2% | 0.00% | -100.0% |
| Q2 2021 | $962,000 | +34.9% | 14,257 | +13.2% | 0.00% | – |
| Q1 2021 | $713,000 | -63.2% | 12,594 | -47.0% | 0.00% | -100.0% |
| Q4 2020 | $1,936,000 | +45.3% | 23,761 | +27.1% | 0.00% | 0.0% |
| Q3 2020 | $1,332,000 | -34.4% | 18,693 | -24.3% | 0.00% | -50.0% |
| Q2 2020 | $2,032,000 | +68.2% | 24,702 | +20.3% | 0.00% | +100.0% |
| Q1 2020 | $1,208,000 | -56.9% | 20,537 | -24.2% | 0.00% | -50.0% |
| Q4 2019 | $2,801,000 | +167.0% | 27,098 | -47.7% | 0.00% | +100.0% |
| Q3 2019 | $1,049,000 | -35.7% | 51,828 | -18.2% | 0.00% | 0.0% |
| Q2 2019 | $1,632,000 | +23.5% | 63,381 | -31.7% | 0.00% | 0.0% |
| Q1 2019 | $1,321,000 | – | 92,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |